Skip to main content
RGA logo

RGA · Reinsurance Group Of America Inc

Track RGA — free
$271.86 -3.29 (-1.20%) At close · Nov 16
Market Cap
$17.68B
Shares
65.05M
Volume · Nov 16 513.14K Avg daily vol (3M) 402.16K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$271.86 Open$276.32 Day$270.66–276.65 52W close$184.10–275.15 Avg vol 30d477K Short int982K · 1.5% of shares · 2.5d Short vol54% Last earningsNov 6, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 6

Up next

Feb 5, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Nov 6
Earnings call
Pre-tax adjusted operating income reached $736 million

RGA earned $736 million in third-quarter pre-tax adjusted operating income, or $8.49 per share after tax, while trailing-12-month adjusted operating ROE reached 19.1%. Total premiums excluding PRT grew 8.9% year-to-date, and the company returned $139 million to shareholders.

4 source passages
RGA earned pre-tax adjusted operating income of $736 million for the quarter, or $8.49 per share after tax. Over the trailing 12 months, our adjusted operating return on equity was 19.1%, excluding AOCI and notable items. Total premiums excluding PRT year-to-date grew 8.9% or 8.2% constant currency, which reflects our strong business momentum. We returned $139 million to shareholders in the quarter, including $75 million in share repurchases. Open the document at this passage
Nov 6
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Nine-month pretax income rises $640 million to $1,670 million

Reinsurance Group of America, Incorporated reported nine-month 2026 income before income taxes of $1,670 million, up $640 million, driven primarily by the Equitable Holdings transaction and higher variable investment income, partly offset by higher investment-related losses.

Revenue $7.55B ▲ 21.7% Net income $456M ▲ 80.2% Diluted EPS $6.92 ▲ 81.6%
Read from the MD&A section
5 source passages
Income before income taxes increased by $640 million for the nine months ended September 30, 2026, compared with the same period in 2025. | Income before income taxes | 624 | 320 | 304 | 1,670 | 1,030 | 640 | The Company executed reinsurance contracts with subsidiaries of Equitable Holdings, Inc. (the “Equitable Holdings Transaction”) on July 31, 2025. Higher variable investment income primarily from limited partnerships and real estate joint venture sales, which increased revenues and contributed to the improvement in income before income taxes. Higher investment related losses resulting from realized losses due to portfolio repositioning and unrealized losses due to changes in fair value of certain limited partnership investments. Open the document at this passage
Nov 5
Current report 8-K
Third-quarter net income rises to $456 million; dividend declared

Reinsurance Group of America, Incorporated reported third-quarter net income of $456 million, or $6.92 per diluted share, versus $253 million and $3.81 per diluted share. It returned $139 million and declared a $0.98 dividend payable December 1, 2026.

Financial results, Regulation FD disclosure Read from the first part of this long document
3 source passages
Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global provider of life and health reinsurance, reported third quarter net income available to RGA shareholders of $456 million, or $6.92 per diluted share, compared with $253 million, or $3.81 per diluted share, in the prior-year quarter. Returned $139 million to shareholders in the quarter, including $75 million in share repurchases and $64 million in dividends paid. The Earnings Release announced that the board of directors declared a regular quarterly dividend of $0.98, payable December 1, 2026, to shareholders of record as of November 17, 2026. Open the document at this passage
Aug 7
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $6.64B ▲ 18.5% Net income $462M ▲ 156.7% Diluted EPS $7.01 ▲ 159.6%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$27.32B
Trailing 12 months
Net income (TTM)
$1.71B
Trailing 12 months
Revenue growth YoY
+21.7%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
10.6
Trailing earnings · reciprocal yield 9.4%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$662.00M
Latest balance sheet
Dividend yield
1.0%
Trailing 12 months
Shares change YoY
-1.5%
Year over year · fewer shares
Price change (1Y)
+44.5%
Trailing year
Short interest
1.5%
Latest settlement · 2.5 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 6, 2026
Q3 FY26

TL;DR. RGA reported sharply higher adjusted operating earnings, 19.1% trailing adjusted operating ROE, 25.0% premium growth, strong investment income, and $139 million of shareholder returns. Offsetting headwinds included weaker Asia Pacific traditional claims results, foreign-currency and tax pressure, an unfavorable EMEA assumption-review impact, expected normalization of alternative investment returns, and the medical excess business rolling off.

Bullish
  • + Adjusted operating income increased to $8.49 per diluted share from $4.66 in the prior-year quarter.
  • + Trailing-twelve-month adjusted operating ROE excluding notable items was 19.1%.
  • + Consolidated net premiums increased 25.0% to $5.4 billion from the prior-year quarter.
  • + Investment income excluding spread-based businesses increased 17.5% from the prior-year quarter.
  • + RGA completed four pension risk transfer transactions totaling over $800 million in combined premium.
  • + RGA returned $139 million to shareholders in the quarter through $75 million of repurchases and $64 million of dividends.
Bearish
  • − Asia Pacific Traditional results excluding notable items decreased from the prior-year quarter due to less favorable claims experience.
  • − The EMEA Traditional segment incurred a $31 million unfavorable impact from the annual actuarial assumption review.
  • − Foreign currency fluctuations reduced net income by $0.11 per diluted share and adjusted operating income by $0.15 per diluted share.
  • − The 24.1% adjusted operating tax rate exceeded the expected 22% to 23% range.
  • − Management does not expect to repeat the quarter's high level of alternative investment returns in the fourth quarter.
  • − The medical excess business is rolling off beginning in 2027 and will become smaller.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very Low
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Strong Buy
50 / 200-day cross No cross
Price vs 200-day avg +19%
above
Price vs 50-day avg +5%
above
RSI (14) 60
neutral
MACD trend Positive
52-week position 96%
near high
Momentum
relative strength
Very Strong
1-month return +2%
trailing
6-month return +31%
trailing
YTD return +34%
this year
Relative strength +33%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $258 › 200d $229 — 50d above 200d
Institutional flow Distributing
-7% holders QoQ · +91 funds added
Insider flow Distributing
Net -$1.0M over 90 days · 100% sells
Short interest Falling
1.51% of shares out · ▼ -5.6% MoM · 2.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
595 holders — mid 3-yr range
Squeeze score 48
elevated · 0–100
Fundamentals
Strong
Revenue growth +7%
Y/Y
EPS growth +65%
Y/Y
Free cash flow $4.1B
Valuation P/E 10.5
rich
Buyback $325.0M
remaining
Balance sheet $1.5B
net debt
Quant / Vol
risk profile
Very Low
Volatility 22%
annualized · 1-yr
Max drawdown −13%
past year
ATR 2.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 7, 2026
this September
Use of excess capital to pay down debt $400M
intermediate term
Payout ratio 20% – 30%
ROE 13% – 15%
intermediate-term
EPS growth 8% – 10%
Previous outlook earlier release · from the Earnings Call filed May 8, 2026

Still-open targets the latest release did not restate under the same label.

Total shareholder return of capital · long term 20% – 30%
Excess capital allocation to reduce financial leverage · 2026 $400M
Prior guidance period ended · from the 8-K filed Nov 5, 2026
Effective tax rate on pre-tax income · the quarter 22% – 23%
Effective tax rate on adjusted operating income before taxes · the quarter 22% – 23%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 2 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+19% Bullish
Price vs 50-day avg
+5% Bullish
RSI (14)
60 Neutral
MACD trend
Positive Bullish
52-week position
96% Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $258 › 200d $229 — 50d above 200d
Institutional flow Distributing
-7% holders QoQ · +91 funds added
Insider flow Distributing
Net -$1.0M over 90 days · 100% sells
Short interest Falling
1.51% of shares out · ▼ -5.6% MoM · 2.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
595 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $184 Now $272 · 96% Range high $275
vs 200-day avg +19% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Annualized investment yield (ratio of net investment income to average invested assets at amorti 5.26% Three months ended September 30, 2026 filing —
Annualized investment yield excluding VII (ratio of net investment income, excluding VII, to ave 4.96% Three months ended September 30, 2026 filing —
Average invested assets at amortized cost $50.38B Three months ended September 30, 2026 filing —
Effect of actual variances from expected experience -$23M three months ended September 30, 2026 filing —
net unfavorable assumptions updates $31M three months ended September 30, 2026 filing —
Run-off of existing in force transactions 1.8B Three months ended September 30, 2026 filing —
VII (included in net investment income) $55M Three months ended September 30, 2026 filing —
Adjusted operating income before income taxes non-GAAP $761M the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Income before income taxes $605M
+$181M Investment and derivative (gains) losses
-$26M Market risk benefits remeasurement (gains) losses
+$1M Change in fair value of funds withheld embedded derivatives
+$10M Funds withheld (gains) losses – investment income
+$0M Derivatives – interest credited
+$0M Investment income on unit-linked variable annuities
+$0M Interest credited on unit-linked variable annuities
+$0M Interest expense on uncertain tax positions
-$10M Other
= Adjusted operating income before income taxes $761M
Other operating expenses as a percentage of net premiums 6.4% Three months ended June 30, 2026 filing —
Policy acquisition costs and other insurance expenses as a percentage of net premiums 4.4% Three months ended June 30, 2026 filing —
Adjusted operating income non-GAAP $1.05B Six Months Ended June 30, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net income available to RGA shareholders 1.51B
+462M Capital (gains) losses, derivatives and other, net
-24M Change in fair value of embedded derivatives
-80M Tax expense on uncertain tax positions and other tax related items
+7M Net income attributable to noncontrolling interest
= Adjusted operating income 1.87B
Assumed life reinsurance in force 4.34T At June 30, 2026 —
Assumed new business production 280.3B Six Months Ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance - Reinsurance — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RGA
Reinsurance Group Of America Inc
this stock
$17.68B +33.6% +7.2% 10.5 1.5%
EG
Everest Group, Ltd.
$16.04B +27.6% +1.2% 9.2 4.1%
RNR
Renaissancere Holdings Ltd
$14.41B +26.8% +9.9% 5.9 2.9%
SPNT
SiriusPoint Ltd
$3.04B +20.7% +23.1% 6.5 4.6%
HG
Hamilton Insurance Group, Ltd.
$2.56B +38.5% +24.7% — 2.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
595
% held
84.8%
Net QoQ
-9.8M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
566
View
Short & Settlement
Short Interest Falling
Shares short
982.1K
Days to cover
2.5d
Change
-58.5K sh
View
Short Volume
Short vol %
54%
As of
Nov 16, 2026
Short Total
View
Fails to Deliver
FTD shares
13
Value
$3.2K
As of
Oct 2, 2026
View
Off-Exchange
Off-exchange %
42.5%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$1.0M
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
John James
Amount
$1.0K–$15.0K
Traded
Sep 4, 2024
View
Financials
Financials
Revenue (FY)
$23.7B
Net income (FY)
$1.2B
EPS diluted
$17.69
View
Buybacks
Authorized
$500.0M
Remaining
$325.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 6, 2026
This year
20

Reinsurance Group of America, Incorporated reported nine-month 2026 income before income taxes of $1,670 million, up $640 million, driven primarily by the Equitable Holdings transaction and higher variable investment income, partly offset by higher investment-related losses.

View
Proposed Sales
Value
$1.0M
Shares
3.9K
Filed
Nov 10, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 6, 2026
View
Investor Relations
Latest news
REINSURANCE GROUP OF AMERICA ANNO…
Published
Nov 5, 2026
View

Performance

5D 20D 120D MTD YTD
RGA +1.9% +1.9% +31.5% +2.7% +33.6%
SPY -1.7% -3.5% -1.4% -2.1% +8.5%
vs SPY +3.6% +5.4% +32.9% +4.8% +25.1%

Capital returns

Latest dividend
$0.98 / share · ex Nov 17, 2026
Raised 5.4%
Paid (TTM)
$3.82 / share · 4 payouts
Dividend yield (TTM, derived)
1.41%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$500.00M
Spent (derived)
$175.00M
Remaining
$325.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 898174 CUSIP 759351604 13F (30d) 582 filings 539 filers Visit website Investor relations